Literature DB >> 23895325

Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression.

Shu-Jen Chen1, Julie Johnston, Arbans Sandhu, Lawrence T Bish, Ruben Hovhannisyan, Odella Jno-Charles, H Lee Sweeney, James M Wilson.   

Abstract

The ability to regulate both the timing and specificity of gene expression mediated by viral vectors will be important in maximizing its utility. We describe the development of an adeno-associated virus (AAV)-based vector with tissue-specific gene regulation, using the ARGENT dimerizer-inducible system. This two-vector system based on AAV serotype 9 consists of one vector encoding a combination of reporter genes from which expression is directed by a ubiquitous, inducible promoter and a second vector encoding transcription factor domains under the control of either a heart- or liver-specific promoter, which are activated with a small molecule. Administration of the vectors via either systemic or intrapericardial injection demonstrated that the vector system is capable of mediating gene expression that is tissue specific, regulatable, and reproducible over induction cycles. Somatic gene transfer in vivo is being considered in therapeutic applications, although its most substantial value will be in basic applications such as target validation and development of animal models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895325      PMCID: PMC3753727          DOI: 10.1089/hgtb.2012.129

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  37 in total

1.  AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.

Authors:  Sang Ryong Kim; Tatyana Kareva; Olga Yarygina; Nikolai Kholodilov; Robert E Burke
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.

Authors:  A Geisler; A Jungmann; J Kurreck; W Poller; H A Katus; R Vetter; H Fechner; O J Müller
Journal:  Gene Ther       Date:  2010-11-04       Impact factor: 5.250

3.  Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.

Authors:  Maria P Limberis; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

4.  Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9.

Authors:  Y Masamizu; T Okada; K Kawasaki; H Ishibashi; S Yuasa; S Takeda; I Hasegawa; K Nakahara
Journal:  Neuroscience       Date:  2011-07-18       Impact factor: 3.590

5.  Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice.

Authors:  Rita Sarkar; Melinda Mucci; Sankar Addya; Renee Tetreault; Dwight A Bellinger; Timothy C Nichols; Haig H Kazazian
Journal:  Hum Gene Ther       Date:  2006-04       Impact factor: 5.695

6.  Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

Authors:  Alberto Auricchio; Victor M Rivera; Tim Clackson; Erin E O'Connor; Albert M Maguire; Michael J Tolentino; Jean Bennett; James M Wilson
Journal:  Mol Ther       Date:  2002-08       Impact factor: 11.454

7.  Construction and analysis of compact muscle-specific promoters for AAV vectors.

Authors:  B Wang; J Li; F H Fu; C Chen; X Zhu; L Zhou; X Jiang; X Xiao
Journal:  Gene Ther       Date:  2008-06-19       Impact factor: 5.250

8.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat.

Authors:  Lawrence T Bish; Kevin Morine; Meg M Sleeper; Julio Sanmiguel; Di Wu; Guangping Gao; James M Wilson; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

9.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Authors:  Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

10.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

View more
  13 in total

Review 1.  Gene therapy for the treatment of heart failure: promise postponed.

Authors:  Jean-Sebastien Hulot; Kiyotake Ishikawa; Roger J Hajjar
Journal:  Eur Heart J       Date:  2016-02-27       Impact factor: 29.983

2.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

3.  Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells.

Authors:  Benjamin Strobel; Benedikt Klauser; Jörg S Hartig; Thorsten Lamla; Florian Gantner; Sebastian Kreuz
Journal:  Mol Ther       Date:  2015-07-03       Impact factor: 11.454

Review 4.  Gene Therapy for Acquired and Genetic Cholestasis.

Authors:  Javier Martínez-García; Angie Molina; Gloria González-Aseguinolaza; Nicholas D Weber; Cristian Smerdou
Journal:  Biomedicines       Date:  2022-05-26

5.  Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.

Authors:  Sarah C Nicolson; Chengwen Li; Matthew L Hirsch; Vincent Setola; R Jude Samulski
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 6.  Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.

Authors:  Kenneth R Chien; Lior Zangi; Kathy O Lui
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

Review 7.  Next-generation AAV vectors for clinical use: an ever-accelerating race.

Authors:  Jonas Weinmann; Dirk Grimm
Journal:  Virus Genes       Date:  2017-07-31       Impact factor: 2.332

Review 8.  Tissue and cell-type-specific transduction using rAAV vectors in lung diseases.

Authors:  Konstantin Kochergin-Nikitsky; Lyubava Belova; Alexander Lavrov; Svetlana Smirnikhina
Journal:  J Mol Med (Berl)       Date:  2021-05-21       Impact factor: 4.599

9.  Downregulation of the β1 adrenergic receptor in the myocardium results in insensitivity to metoprolol and reduces blood pressure in spontaneously hypertensive rats.

Authors:  Yun Huang; Xiao-Li Liu; Jia Wen; Li-Hua Huang; Yao Lu; Ru-Jia Miao; Xing Liu; Ying Li; Xiao-Wei Xing; Hong Yuan
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

10.  AAVvector-mediated in vivo reprogramming into pluripotency.

Authors:  Elena Senís; Lluc Mosteiro; Stefan Wilkening; Ellen Wiedtke; Ali Nowrouzi; Saira Afzal; Raffaele Fronza; Henrik Landerer; Maria Abad; Dominik Niopek; Manfred Schmidt; Manuel Serrano; Dirk Grimm
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.